FusionVAC22_01

· University Hospital Tuebingen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FusionVAC22_01, covering 2024-12-09 to 2024-12-09. Get the full timeline:

Most recent: Clinical Trial Update: FusionVAC22_01: Fusion Transcript-based Peptide Vaccine Combined with Immune Checkpoint Inhibition [Phase 1]